Ausgabe 3-4/2009
Special Issue: Urological Cancers; Guest Editors: David J. McConkey
Inhalt (12 Artikel)
Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications
Xifeng Wu, Michelle A. T. Hildebrandt, David W. Chang
Open Access
Biology of urothelial tumorigenesis: insights from genetically engineered mice
Xue-Ru Wu
Urothelial carcinoma: Stem cells on the edge
William D. Brandt, William Matsui, Jonathan E. Rosenberg, Xiaobing He, Shizhang Ling, Edward M. Schaeffer, David M. Berman
Open Access
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
Margaret A. Knowles, Fiona M. Platt, Rebecca L. Ross, Carolyn D. Hurst
Strategies for molecular expression profiling in bladder cancer
Anirban P. Mitra, Claudia C. Bartsch, Richard J. Cote
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
David J. McConkey, Woonyoung Choi, Lauren Marquis, Frances Martin, Michael B. Williams, Jay Shah, Robert Svatek, Aditi Das, Liana Adam, Ashish Kamat, Arlene Siefker-Radtke, Colin Dinney
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette–Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder
Henry M. Rosevear, Andrew J. Lightfoot, Michael A. O’Donnell, Thomas S. Griffith
Emerging targeted therapies for bladder cancer: a disease waiting for a drug
Simon J. Dovedi, Barry R. Davies
NON-THEMATIC REVIEW
MicroRNA function in cancer: oncogene or a tumor suppressor?
Sylvia K. Shenouda, Suresh K. Alahari